NIH to fund Pentagon biodefense research under new agreement

September 9, 2026 at 01:06 AM1 min

This digest was compiled by AI from multiple sources — links to the originals are below.

The National Institutes of Health will use part of its budget to fund Department of Defense research on pandemic strains and CBRN threats under a new agreement. Senator Patty Murray accused the parties of transferring money to the Pentagon without congressional approval. The deal includes research NIH leadership previously rejected.

Key Facts

The agreement will use NIH funds for research to protect against future pandemic strains, CBRN threats, and emerging infectious diseases.
Senator Patty Murray accused the parties of using the agreement to transfer money to the Pentagon without congressional approval.
NIH leadership previously called for dropping biodefense research from the agency's remit, including pandemic preparedness.
The agreement is vague, making its consequences difficult to determine until spending data becomes available.

Funding Transfer

The National Institutes of Health will allocate part of its budget to the Department of Defense for biodefense research. Senator Patty Murray said the agreement transfers money to the Pentagon without congressional approval. The deal includes funding for research on pandemic strains, CBRN threats, and emerging infectious diseases.

Policy Reversal

Prior to the Trump administration, NIAID funded research on emerging disease biology and potential defenses. In a commentary published early this year, NIAID and NIH heads called for dropping biodefense research and pandemic preparedness. The new agreement funds research that NIH leadership explicitly rejected.

Congressional Response

Some suggest the agreement is part of a longer-term effort to shift biosecurity research from NIH to the Pentagon. Future Congresses may prohibit this type of spending, based on recent actions. The agreement's vagueness makes its consequences difficult to assess until spending data is available.